Therapeutic Alliance is it Associated With Better Compliance Amongst Children With Juvenile Idiopathic Arthritis ?

NCT ID: NCT02824978

Last Updated: 2018-07-12

Basic Information

• Recruitment Status: COMPLETED
• Total Enrollment: 120 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2016-10-07
• Study Completion Date: 2018-01-01

Brief Summary

to evalute if therapeutic alliance is related to adherence in JIA

Detailed Description

The therapeutic alliance is the agreement that is being built between doctor and patient during the construction process of care. So active collaboration based on a shared assessment of issues and agreement on possible solutions. Initially described in psychiatry, this analytical concept has been extended to several chronic diseases in particular requiring more often a strong link between doctor and patient. His measure is important since it has been demonstrated by several previous studies that the therapeutic alliance is predictive of the therapeutic effects of treatment. This alliance, however, was little studied in juvenile idiopathic arthritis, its connection with the observance or the quality of life has never been evaluated.

The chronic nature of juvenile idiopathic arthritis (JIA) requires a strong ability of the child to follow his treatment, where the role of parents going to be important and where the relationship built with the caregiver is also essential.

Adherence is a complex concept for which there is no ideal measure. Direct evaluation criteria such as bioassays prove still incomplete and difficult to implement in observational studies. Indirect measures have been developed through self-administered questionnaires and literature showed their relatively good correlation with actual catches. The innovative hypothesis of this research is that a better therapeutic alliance is associated with better adherence child in JIA.

Conditions

Juvenile Idiopathic Arthritis

Study Design

• Observational Model Type: COHORT
• Study Time Perspective: PROSPECTIVE

Eligibility Criteria

Inclusion Criteria

• Patients with JIA (see classification above)
• Aged at least 8 to 18 years.
• Having already seen more than 2 times in consultation with the referring physician will even include the child in the study so that the alliance could build process
• Children can read, understand and complete questionnaires
• No opposition made

Exclusion Criteria

• Systemic form of JIA;
• Children aged under 8 years old or over 18 years;
• Child or parent does not understand French
• Refusal of participation

• Minimum Eligible Age: 8 Years
• Maximum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

University Hospital, Brest

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Valérie Devauchelle-Pensec, Professor

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Brest

Locations

CHU Angers

Angers, , France

Hôpital Nord Franche Comté

Belfort, , France

CHRU Besançon

Besançon, , France

CHU Bordeaux

Bordeaux, , France

CHRU Brest

Brest, , France

Hôpital Femme-Mère-Enfant - HCL

Bron, , France

CHU Dijon

Dijon, , France

CHU Martinique

Fort-de-France, , France

Hôpital Bicêtre - APHP

Le Kremlin-Bicêtre, , France

CHRU Lille

Lille, , France

CH Mulhouse

Mulhouse, , France

CHU Nîmes

Nîmes, , France

Hôpital Necker-Enfants Malades - APHP

Paris, , France

CHU Poitiers

Poitiers, , France

CHU Rennes

Rennes, , France

CHRU Strasbourg

Strasbourg, , France

CHU Nancy

Vandœuvre-lès-Nancy, , France

Countries

France

Other Identifiers

ALLIANCE (RB 16.004 )

Identifier Type: -

Identifier Source: org_study_id